Gene · 825
Papers1,501
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,501
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical and bi-genomic DNA findings of patients suspected to have mitochondrial diseases. | Front Genet | 2023 | 37377599 | PubTator, text mining | PubMed |
| The Importance of Implementing a Transition Strategy for Patients with Muscular Dystrophy: From Child to Adult-Insights from a Tertiary Centre for Rare Neurological Diseases. | Children (Basel) | 2023 | 37371191 | PubTator, text mining | PubMed |
| Clusters of rare disorders and congenital anomalies in South America. | Rev Panam Salud Publica | 2023 | 37363626 | PubTator, text mining | PubMed |
| Report and Abstracts of the 19th Meeting of the Interuniversity Institute of Myology: Assisi, October 20-23, 2022. | Eur J Transl Myol | 2023 | 37326466 | PubTator, text mining | PubMed |
| Urinary titin N-fragment as a predictor of decreased skeletal muscle mass in patients with interstitial lung diseases. | Sci Rep | 2023 | 37322176 | PubTator, text mining | PubMed |
| Calpain-3 Is Not a Sodium Dependent Protease and Simply Requires Calcium for Activation. | Int J Mol Sci | 2023 | 37298357 | PubTator, text mining | PubMed |
| Oxidative Stress in Melanoma: Beneficial Antioxidant and Pro-Oxidant Therapeutic Strategies. | Cancers (Basel) | 2023 | 37297001 | PubTator, text mining | PubMed |
| Genome sequencing with comprehensive variant calling identifies structural variants and repeat expansions in a large fraction of individuals with ataxia and/or neuromuscular disorders. | Front Neurol | 2023 | 37273706 | PubTator, text mining | PubMed |
| Muscle Specific Promotors for Gene Therapy - A Comparative Study in Proliferating and Differentiated Cells. | J Neuromuscul Dis | 2023 | 37270809 | PubTator, text mining | PubMed |
| Single-nucleus and bulk RNA sequencing reveal cellular and transcriptional mechanisms underlying lipid dynamics in high marbled pork. | NPJ Sci Food | 2023 | 37268610 | PubTator, text mining | PubMed |
| A 53-year-old man with a 16-year history of asymmetrical proximal muscle weakness, facial muscle weakness, and scapular winging. | Brain Pathol | 2023 | 37259682 | PubTator, text mining | PubMed |
| Microalgae Produce Antioxidant Molecules with Potential Preventive Effects on Mitochondrial Functions and Skeletal Muscular Oxidative Stress. | Antioxidants (Basel) | 2023 | 37237915 | PubTator, text mining | PubMed |
| [Molecular therapies: present and future in neuromuscular diseases]. | Nervenarzt | 2023 | 37221259 | PubTator, text mining | PubMed |
| Genome-wide mRNA profiling in urinary extracellular vesicles reveals stress gene signature for diabetic kidney disease. | iScience | 2023 | 37216114 | PubTator, text mining | PubMed |
| A Case of Cardiogenic Stroke With a Novel LMNA Variant (c. 1135C>A; p.Leu379Ile). | Cureus | 2023 | 37213971 | PubTator, text mining | PubMed |
| The function of histone methylation and acetylation regulators in GBM pathophysiology. | Front Oncol | 2023 | 37205197 | PubTator, text mining | PubMed |
| Identification of Extremely Rare Pathogenic CNVs by Array CGH in Saudi Children with Developmental Delay, Congenital Malformations, and Intellectual Disability. | Children (Basel) | 2023 | 37189911 | PubTator, text mining | PubMed |
| Identical tau filaments in subacute sclerosing panencephalitis and chronic traumatic encephalopathy. | Acta Neuropathol Commun | 2023 | 37143123 | PubTator, text mining | PubMed |
| SUMOylation patterns and signature characterize the tumor microenvironment and predict prognosis in lung adenocarcinoma. | Front Cell Dev Biol | 2023 | 37123398 | PubTator, text mining | PubMed |
| French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes. | Orphanet J Rare Dis | 2023 | 37122022 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/825/papers?page=8